MNA
BSX icon

Manning & Napier Advisors’s Boston Scientific BSX Stock Holding History

Manning & Napier Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35K Buy
+100
New +$5.43K ﹤0.01% 612

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Manning & Napier Advisors's BSX Position: Q2 2026 in Review

Manning & Napier Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 100 shares worth $4.35K. The stake represents ﹤0.01% of the portfolio and ranks #612 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Manning & Napier Advisors held 100 shares of Boston Scientific worth $4.35K as of Q2 2026.
  • Boston Scientific was a new Manning & Napier Advisors position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #612 holding.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.